EXOZ — eXoZymes Cashflow Statement
0.000.00%
Last trade - 00:00- $120.27m
- $115.29m
Annual cashflow statement for eXoZymes, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS/A | PROSPECTUS | PROSPECTUS | 10-K |
| Standards: | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final |
| Net Income/Starting Line | -1.21 | -1.4 | -2.04 | -5.86 |
| Depreciation | ||||
| Non-Cash Items | 0.099 | 0.181 | 0.44 | 1.11 |
| Unusual Items | ||||
| Other Non-Cash Items | ||||
| Changes in Working Capital | -0.536 | -0.19 | 0.22 | -4.02 |
| Change in Accounts Receivable | ||||
| Change in Prepaid Expenses | ||||
| Change in Accounts Payable | ||||
| Change in Taxes Payable | ||||
| Net Change in Other Assets & Liabilities | ||||
| Cash from Operating Activities | -1.59 | -1.26 | -1.18 | -8.51 |
| Capital Expenditures | -0.423 | -0.186 | -0.289 | -0.396 |
| Purchase of Fixed Assets | ||||
| Other Investing Cash Flow Items | 0.11 | 0.099 | -0.022 | 0.037 |
| Other Investing Cash Flow | ||||
| Cash from Investing Activities | -0.312 | -0.087 | -0.311 | -0.359 |
| Financing Cash Flow Items | — | 0 | 1 | — |
| Other Financing Cash Flow | ||||
| Net Issuance / Retirement of Stock | ||||
| Net Issuance / Retirement of Debt | ||||
| Cash from Financing Activities | 2.31 | 1.36 | 1 | 18.5 |
| Beginning Cash Balance | ||||
| Ending Cash Balance | ||||
| Net Change in Cash | 0.413 | 0.011 | -0.492 | 9.65 |